(Q42831158)

8 November 2017

title

Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model (English)

1 reference

8 November 2017

D Céfai

1

1 reference

8 November 2017

L Favre

2

1 reference

8 November 2017

E Wattendorf

3

1 reference

8 November 2017

A Marti

4

1 reference

8 November 2017

R Jaggi

5

1 reference

8 November 2017

C D Gimmi

6

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

International Journal of Cancer

8 November 2017

published in

1 reference

8 November 2017

volume

91

1 reference

8 November 2017

issue

4

1 reference

8 November 2017

page(s)

529-537

1 reference

Human tumor antigens recognized by T lymphocytes

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Stability of HER-2/neu expression over time and at multiple metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Induction of apoptosis in mature T cells by tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Fas counter-attack–the best form of tumor defense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Antitumor effect of locally produced CD95 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

Attempts to reveal the mechanism of CD95-ligand-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

CD95 ligand expression as a mechanism of immune escape in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1074%3E3.0.CO%3B2-O

10.1002/1097-0215(200002)9999:9999<::AID-IJC1074>3.0.CO;2-O

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference